Mergers & Acquisitions and Other Corporate Transactions
Representations in select corporate transactions include:
- A global biopharmaceutical company in connection with its approximately $20 billion concurrent acquisitions of two publicly traded biotechnology companies.
- A publicly traded life sciences company in its approximately $6 billion cross-border sale to a global health care conglomerate.
- A California-based health care services company in its approximately $745 million sale to a strategic buyer.
- A biotechnology company in connection with its ex-U.S. licensing agreement with a leading European specialist pharmaceutical company.
- A foreign biotechnology company in its $236 million U.S. initial public offering.
- A sovereign wealth fund in its minority investment in a major professional sports and entertainment holding company.
- A pharmaceutical company in the $400 million sale of a consumer health subsidiary pursuant to a competitive sale process.
- A publicly traded special purpose acquisition company in its $300 million business combination with a natural resources company.
*Not admitted to practice in the Commonwealth of Pennsylvania. Admitted to practice in the State of New York and District of Columbia only. Practice limited to commercial transactions and corporate matters.